Mutational analysis of a cohort with clinical diagnosis of familial hypercholesterolemia: considerations for genetic diagnosis improvement
Author(s) -
Ana Margarida Medeiros,
Ana Catarina Alves,
Mafalda Bourbon
Publication year - 2015
Publication title -
genetics in medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.509
H-Index - 128
eISSN - 1530-0366
pISSN - 1098-3600
DOI - 10.1038/gim.2015.71
Subject(s) - familial hypercholesterolemia , apolipoprotein b , pcsk9 , genetic diagnosis , medicine , genetic testing , ldl receptor , genetics , genetic counseling , identification (biology) , cohort , genetic disorder , bioinformatics , biology , disease , cholesterol , gene , lipoprotein , botany
Familial hypercholesterolemia (FH) is a common autosomal dominant disorder of lipid metabolism caused by mutations in LDLR, APOB, and PCSK9. To fulfill the World Health Organization recommendation, the Portuguese FH Study was established. Here, we report the results of the past 15 years and present practical considerations concerning the genetic diagnosis of FH based on our experience.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom